26.06.2017 • News

Polytek and CMI Set to Merge

(c) XXLPhoto/Shutterstock
(c) XXLPhoto/Shutterstock

US specialty polymer firms Polytek Development Corp. and California Medical Innovations (CMI) are to merge their businesses. The combined company will be led by Polytek CEO Jonathan Kane.

Financial terms of the transaction were not disclosed.

"The merger of the two companies creates a portfolio of products for our industries, unmatched by any competitor in the world, with a coast-to-coast presence that allows us to respond more quickly than ever before," Kane said.

Based in Easton, Pennsylvania, Polytek makes specialty polymers, including polyurethane elastomers and casting resins, silicones, epoxies and latex, used primarily in mold-making and casting applications for the industrial, construction, entertainment, fine arts and technology sectors.

CMI of Pomona, California, formulates and compounds latex, plastisols and thermoplastic elastomers for a variety of industries.

The companies said the merger will enhance their performance and provide a stronger nationwide presence. In addition, the collaboration of their R&D departments and sophisticated manufacturing facilities at both locations will offer more opportunities for customized solutions.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

On Demand | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.